Literature DB >> 19081305

Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: implications for the development of acute graft-versus host disease.

Rudolf Horváth1, Vít Budinský, Jana Kayserová, Tomás Kalina, Renata Formánková, Jan Starý, Jirina Bartůnková, Petr Sedlácek, Radek Spísek.   

Abstract

Allogeneic hematopoetic stem cell transplantation (HSCT) represents a unique opportunity to monitor the kinetics of reconstitution of dendritic cells (DCs) and their dynamics in distinct pathologies. We analyzed DCs reconstitution after myeloablative HSCT. We separately analyzed patients with acute GVHD. DCs were monitored from the earliest phase of hematopoetic reconstitution until day +365. Both myeloid DCs and plasmacytoid DCs appeared at earliest stages after engraftment and relative numbers within white blood cells compartment peaked between days 19-25 after HSCT. Their proportion then gradually declined and absolute numbers of both DC subsets remained lower than in controls during the whole follow-up. Patients with acute GVHD had significantly lower numbers of circulating DCs. Decrease in DC counts preceded onset of clinical symptoms by at least 24 h and was independent of corticosteroids administration. This study reveals quantification of plasmacytoid and myeloid DCs as a potential biomarker for the prediction of acute GVHD development.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19081305     DOI: 10.1016/j.clim.2008.10.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  12 in total

1.  Preconditioning therapy with lentiviral vector-programmed dendritic cells accelerates the homeostatic expansion of antigen-reactive human T cells in NOD.Rag1-/-.IL-2rγc-/- mice.

Authors:  Gustavo Salguero; Bala Sai Sundarasetty; Sylvia Borchers; Dirk Wedekind; Britta Eiz-Vesper; Sarvari Velaga; Adan C Jirmo; Georg Behrens; Gregor Warnecke; Ann-Kathrin Knöfel; Rainer Blasczyk; Eva Mischak-Weissinger; Arnold Ganser; Renata Stripecke
Journal:  Hum Gene Ther       Date:  2011-07-27       Impact factor: 5.695

2.  Case report: type 1 diabetes in monozygotic quadruplets.

Authors:  Katerina Stechova; Zbynek Halbhuber; Miluse Hubackova; Jana Kayserova; Lenka Petruzelkova; Jana Vcelakova; Stanislava Kolouskova; Tereza Ulmannova; Maria Faresjö; Ales Neuwirth; Radek Spisek; Anna Sediva; Dominik Filipp; Zdenek Sumnik
Journal:  Eur J Hum Genet       Date:  2011-11-23       Impact factor: 4.246

3.  Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies.

Authors:  Waseem Touma; Claudio G Brunstein; Qing Cao; Jeffrey S Miller; Julie Curtsinger; Michael R Verneris; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-07-17       Impact factor: 5.742

Review 4.  Dendritic cell recovery post-lymphodepletion: a potential mechanism for anti-cancer adoptive T cell therapy and vaccination.

Authors:  Mohamed Labib Salem; David J Cole
Journal:  Cancer Immunol Immunother       Date:  2009-11-18       Impact factor: 6.968

Review 5.  Plasmacytoid dendritic cells in allogeneic hematopoietic cell transplantation: benefit or burden?

Authors:  J J Auletta; S M Devine; E K Waller
Journal:  Bone Marrow Transplant       Date:  2015-12-07       Impact factor: 5.483

6.  Targeting CD83 for the treatment of graft-versus-host disease.

Authors:  Xiongfei Wang; Ming Q Wei; Xiaosong Liu
Journal:  Exp Ther Med       Date:  2013-04-02       Impact factor: 2.447

Review 7.  The role of dendritic cells in graft-versus-tumor effect.

Authors:  Tomomi Toubai; Nathan Mathewson; Pavan Reddy
Journal:  Front Immunol       Date:  2014-02-21       Impact factor: 7.561

8.  Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.

Authors:  Anouk A J Hamers; Sunil K Joshi; Asha B Pillai
Journal:  OBM Transplant       Date:  2019-01-31

9.  Saikosaponin-d affects the differentiation, maturation and function of monocyte-derived dendritic cells.

Authors:  Zuo-Lin Ying; Xiao-Jie Li; Hong Dang; Feng Wang; Xiao-Yan Xu
Journal:  Exp Ther Med       Date:  2014-02-20       Impact factor: 2.447

10.  TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.

Authors:  Martin Lelaidier; Yildian Dìaz-Rodriguez; Martine Cordeau; Paulo Cordeiro; Elie Haddad; Sabine Herblot; Michel Duval
Journal:  Oncotarget       Date:  2015-10-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.